Thompson Rahsaan 4
4 · Lyell Immunopharma, Inc. · Filed Feb 28, 2023
Insider Transaction Report
Form 4
Thompson Rahsaan
Chief Legal Officer
Transactions
- Award
Option (right to buy)
2023-02-24+245,000→ 245,000 totalExercise: $2.13Exp: 2033-02-23→ Common Stock (245,000 underlying)
Footnotes (1)
- [F1]12.5% of the option shares shall vest on August 9, 2023, with the remaining option shares to vest in equal monthly installments over the following forty-two months.